11:06 AM EST - Nuvo Pharmaceuticals Inc. : Announced Jesse Ledger, Nuvo's President & Chief Executive Officer and Kelly Demerino, Nuvo's Interim Chief Financial Officer will present live at LifeSciencesInvestorForum.com on Thursday, September 17. Nuvo Pharmaceuticals Inc.
shares T.NRI are trading unchanged at $0.78.
